Working… Menu

Rolapitant Plus Olanzapine in Multiday Cisplatin Chemotherapy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03960151
Recruitment Status : Withdrawn (Compound was sold by funder and development ceased.)
First Posted : May 22, 2019
Last Update Posted : May 22, 2019
Tesaro, Inc.
Information provided by (Responsible Party):
Costantine Albany, Hoosier Cancer Research Network

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Estimated Primary Completion Date : May 2021
Estimated Study Completion Date : March 2022